The oncology precision medicine industry is rapidly evolving as cutting-edge technologies increasingly enable personalized cancer treatments tailored to patients’ genetic profiles. Fueled by innovations in genomics and bioinformatics, this sector is witnessing significant advances in targeted therapies, driving transformative outcomes in oncology care and reshaping treatment paradigms...

The global silicone radiopaque vascular ties market is projected to grow from USD 43.6 million in 2026 to USD 58.9 million by 2036, expanding at a 3.4% CAGR, according to Future Market Insights (FMI). The market was valued at approximately USD 42.2 million in 2025, with incremental demand supported by cardiovascular and thoracic surgeries, minimally invasive techniques, and increasing reliance...

The oncology precision medicine industry is experiencing transformative growth driven by advancements in genomic profiling and targeted therapies. This sector is redefining cancer treatment paradigms through personalized approaches, substantially enhancing patient outcomes. The evolving landscape is marked by increased investment in precision diagnostics and biomarker-driven drug development,...